AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21070806 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate‐to‐vigorous intensity aerobic exercise 45 min/day, 5 days/week for 1 year
Number of subjects: 320
Study 21070806 — intervention group
Group type: COMPARATOR
Intervention: Sedentary lifestyle
Number of subjects: 320
Study 19898206 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed tacrolimus with basiliximab and mycophenolate mofetil (Tac‐d)
Number of subjects: 254
Study 19898206 — intervention group
Group type: COMPARATOR
Intervention: Standard tacrolimus with mycophenolate mofetil and steroids until day 91 (Tac‐s)
Number of subjects: 254
Study 18085138 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration treatment group (AMIE methods: acupuncture, massage, injection, and animal exercise therapies)
Number of subjects: 120
Study 18085138 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation group (Bobath training therapy)
Number of subjects: 120
Study 14967451 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR inhibitors (monoclonal antibodies and small molecular weight compounds)
Number of subjects: 0
Study 14967451 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies with EGFR inhibitors
Number of subjects: 0
Study 12588463 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (4.8 microg kg(‐1) bolus followed by 9.6 microg kg(‐1) h(‐1) infusion)
Number of subjects: 8
Study 12588463 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 8
Study 10948696 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.396 microgram administered intravenously as a bolus injection)
Number of subjects: 8
Study 10948696 — intervention group
Group type: EXPERIMENTAL
Intervention: High urine flow rate (indicating overhydration)
Number of subjects: 8
Study 10948696 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect-response model
Number of subjects: 8
Study 7744168 — intervention group
Group type: EXPERIMENTAL
Intervention: High spatial uncertainty
Number of subjects: 72
Study 7744168 — intervention group
Group type: COMPARATOR
Intervention: Low spatial uncertainty
Number of subjects: 72
Study 7744168 — intervention group
Group type: EXPERIMENTAL
Intervention: High event rate with high spatial uncertainty
Number of subjects: 72
Study 1787707 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal application for a week
Number of subjects: 7
Study 1787707 — intervention group
Group type: COMPARATOR
Intervention: No thermal application for a week (Control)
Number of subjects: 7
Study 6957155 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (1200 mg daily)
Number of subjects: 0
Study 6957155 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0
Study 6957155 — intervention group
Group type: COMPARATOR
Intervention: Clofibrate
Number of subjects: 0
Study 6957155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30707138 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 13
Study 30707138 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 13
Study 29185878 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST) for 6 weeks
Number of subjects: 33
Study 29185878 — intervention group
Group type: COMPARATOR
Intervention: Usual care treatment
Number of subjects: 33
Study 27004462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical combination (NC)
Number of subjects: 0
Study 27004462 — intervention group
Group type: COMPARATOR
Intervention: No active treatment (noNC)
Number of subjects: 0
Study 25391355 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography-guided (EG) lead placement strategy
Number of subjects: 183
Study 25391355 — intervention group
Group type: COMPARATOR
Intervention: Routine lead placement strategy
Number of subjects: 183
Study 25391355 — intervention group
Group type: COMPARATOR
Intervention: Patients with QRS > 150 ms
Number of subjects: 183
Study 22943446 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilaminar technique (BT)
Number of subjects: 50
Study 22943446 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally moved, coronally advanced flap (LMCAF)
Number of subjects: 50
Study 22943446 — intervention group
Group type: COMPARATOR
Intervention: Both BT and LMCAF
Number of subjects: 50
Study 20439345 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cisplatin (200 mg/m²) and paclitaxel (135 mg/m²)
Number of subjects: 236
Study 20439345 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (75 mg/m²) and paclitaxel (135 mg/m²)
Number of subjects: 236
Study 17673811 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD regimen (doxorubicin, bleomycin, vinblastine, dacarbazine)
Number of subjects: 40
Study 15620492 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency transcutaneous electrical nerve stimulation
Number of subjects: 19
Study 15620492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 11893434 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy by mothers
Number of subjects: 57
Study 11893434 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy by trained professionals
Number of subjects: 57
Study 11893434 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage therapy)
Number of subjects: 57
Study 9689902 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D administration in addition to Rifampicin, Isoniazid and Streptomycin (Group B)
Number of subjects: 24
Study 9689902 — intervention group
Group type: COMPARATOR
Intervention: Rifampicin, Isoniazid and Streptomycin (Group A)
Number of subjects: 24
Study 8210015 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 204
Study 8210015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 2573240 — intervention group
Group type: EXPERIMENTAL
Intervention: Melperone (300 mg daily)
Number of subjects: 20
Study 2573240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2573240 — intervention group
Group type: EXPERIMENTAL
Intervention: Melperone
Number of subjects: 20
Study 4214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified radical mastectomy
Number of subjects: 0
Study 4214889 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 0
Study 4214889 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 0
Study 4214889 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative irradiation therapy
Number of subjects: 0
Study 31814307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Number of subjects: 20
Study 31814307 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study 29982728 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavored waterpipe tobacco
Number of subjects: 32
Study 29982728 — intervention group
Group type: COMPARATOR
Intervention: Non-flavored waterpipe tobacco
Number of subjects: 32
Study 28590834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharm Booklet
Number of subjects: 402
Study 28590834 — intervention group
Group type: COMPARATOR
Intervention: LONG DA
Number of subjects: 402
Study 28590834 — intervention group
Group type: COMPARATOR
Intervention: SHORT DA
Number of subjects: 402
Study 28590834 — intervention group
Group type: COMPARATOR
Intervention: LONG DA or SHORT DA
Number of subjects: 402
Study 25040553 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP treatment
Number of subjects: 140
Study 25040553 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 140
Study 23477366 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-specific training
Number of subjects: 21
Study 23477366 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 21
Study 21496468 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 20
Study 21496468 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18516713 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 40
Study 18516713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 17296461 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 37.5-mg/acetaminophen 325-mg combination tablets (tramadol/APAP)
Number of subjects: 267
Study 17296461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study 14521597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 14521597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg alternate daily
Number of subjects: 91
Study 14521597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg day-1
Number of subjects: 91
Study 14521597 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg day-1
Number of subjects: 91
Study 11135129 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls and mobility intervention featuring preventive home visits by public health nurses
Number of subjects: 0
Study 9104905 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 6797
Study 9104905 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant monotherapy
Number of subjects: 6797
Study 7962319 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS levels measured 3 times at 6-month intervals in group 1 (elderly women)
Number of subjects: 57
Study 7962319 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS levels measured 6 times over 2 consecutive weeks in group 2 (healthy men)
Number of subjects: 57
Study 7962319 — intervention group
Group type: COMPARATOR
Intervention: Cortisol levels measured concomitantly in both groups
Number of subjects: 57
Study 2442543 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril, 10 mg b.i.d. on a low sodium diet (50 mmol sodium/24 h)
Number of subjects: 10
Study 2442543 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril, 10 mg b.i.d. on a liberal sodium diet (200 mmol sodium/24 h)
Number of subjects: 10
Study 2442543 — intervention group
Group type: COMPARATOR
Intervention: Enalapril, 10 mg b.i.d. on both diets
Number of subjects: 10
Study 31420190 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS pharmaceutical care service (verbal and written educational materials focusing on diet and exercise)
Number of subjects: 118
Study 31420190 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (control group)
Number of subjects: 118
Study 29557402 — intervention group
Group type: EXPERIMENTAL
Intervention: Curvomax abutment
Number of subjects: 49
Study 29557402 — intervention group
Group type: COMPARATOR
Intervention: GingiHue abutment
Number of subjects: 49
Study 27321596 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentraxin 3 (PTX3)
Number of subjects: 1315
Study 27321596 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin
Number of subjects: 1315
Study 26348782 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warming blanket
Number of subjects: 40
Study 26348782 — intervention group
Group type: COMPARATOR
Intervention: Heated overblanket (Control)
Number of subjects: 40
Study 24087999 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (60 mg/day for 8 weeks)
Number of subjects: 0
Study 21816033 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based prevention program 'In control: No alcohol!' consisting of five printed magazines and an activity book
Number of subjects: 0
Study 21816033 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving a factsheet information brochure (standard alcohol brochure of the Trimbos Institute)
Number of subjects: 0
Study 19114142 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program (12 weeks, 3 sessions of 60 min per week)
Number of subjects: 32
Study 16111790 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of live attenuated oral monovalent G1 human rotavirus vaccine
Number of subjects: 100
Study 16111790 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose of live attenuated oral monovalent G1 human rotavirus vaccine
Number of subjects: 100
Study 16111790 — intervention group
Group type: COMPARATOR
Intervention: Routine childhood vaccines
Number of subjects: 100
Study 16111790 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dosages of HRV vaccine
Number of subjects: 100
Study 15130227 — intervention group
Group type: EXPERIMENTAL
Intervention: Early liver retraction
Number of subjects: 12
Study 15130227 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed liver retraction
Number of subjects: 12
Study 10960940 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine/cisplatin regimen
Number of subjects: 0
Study 10960940 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus preoperative gemcitabine/cisplatin
Number of subjects: 0
Study 10960940 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study 9308065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloral hydrate and promethazine
Number of subjects: 42
Study 9308065 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 42
Study 8285331 — intervention group
Group type: EXPERIMENTAL
Intervention: Split laryngeal mask airway
Number of subjects: 30
Study 8285331 — intervention group
Group type: COMPARATOR
Intervention: Berman II airway
Number of subjects: 30
Study 3577278 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g Mezlocillin (Baypen) i.v.
Number of subjects: 60
Study 3577278 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic
Number of subjects: 60
Study 29290380 — intervention group
Group type: COMPARATOR
Intervention: Postoperative IV fluids at the surgeon's discretion
Number of subjects: 0
Study 29290380 — intervention group
Group type: EXPERIMENTAL
Intervention: No postoperative IV fluids
Number of subjects: 0
Study 29290380 — intervention group
Group type: COMPARATOR
Intervention: Control group (IV fluids)
Number of subjects: 0
Study 29290380 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (no IV fluids)
Number of subjects: 0
Study 26549222 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 104
Study 26549222 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 104
Study 26549222 — intervention group
Group type: EXPERIMENTAL
Intervention: OrthoMTA
Number of subjects: 104
Study 26549222 — intervention group
Group type: EXPERIMENTAL
Intervention: ERRM
Number of subjects: 104
Study 26549222 — intervention group
Group type: COMPARATOR
Intervention: Blood contamination
Number of subjects: 104
Study 26549222 — intervention group
Group type: COMPARATOR
Intervention: Saline contamination
Number of subjects: 104
Study 23873670 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO‐5334 50 mg twice daily
Number of subjects: 197
Study 23873670 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO‐5334 100 mg once daily
Number of subjects: 197
Study 23873670 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO‐5334 300 mg once daily
Number of subjects: 197
Study 23873670 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 70 mg once weekly
Number of subjects: 197
Study 23873670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study 22269729 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 82
Study 22269729 — intervention group
Group type: COMPARATOR
Intervention: Bone wax
Number of subjects: 82
Study 19762071 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 260
Study 19762071 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 260
Study 19762071 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 260
Study 17684522 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 70
Study 17684522 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Vitamin A-deficient placebo group)
Number of subjects: 70
Study 17684522 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Vitamin A-sufficient placebo group)
Number of subjects: 70
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Single dose of S-3304 (10 - 800 mg)
Number of subjects: 48
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose of S-3304 (200 mg, 400 mg, 800 mg b.i.d.)
Number of subjects: 48
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose of S-3304 (800 mg b.i.d.)
Number of subjects: 48
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Single dose of S-3304 (800 mg)
Number of subjects: 48
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Single dose of S-3304 (high-fat diet effect)
Number of subjects: 48
Study 15968885 — intervention group
Group type: COMPARATOR
Intervention: Multiple doses of S-3304
Number of subjects: 48
Study 15968885 — intervention group
Group type: EXPERIMENTAL
Intervention: S-3304 (800 mg b.i.d.)
Number of subjects: 48
Study 14629247 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 16
Study 14629247 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 16
Study 14629247 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergotamine tartrate 2 mg
Number of subjects: 16
Study 14629247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 11307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid and wire fixation (intervention group)
Number of subjects: 117
Study 11307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-Surgical Patient Satisfaction Questionnaire (PSPSQ)
Number of subjects: 117
Study 11307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Health Status Questionnaire (OHSQ)
Number of subjects: 117
Study 11307227 — intervention group
Group type: EXPERIMENTAL
Intervention: Eysenck Personality Inventory (EPI), Sickness Impact Profile (SIP), Revised Symptom Checklist‐90 (SCL‐90‐R)
Number of subjects: 117
Study 8885732 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 5 mg orally every 4 hours
Number of subjects: 205
Study 8885732 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium chloride 128 mg orally every 4 hours
Number of subjects: 205
Study 8885732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 8885732 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Placebo, Terbutaline, Magnesium)
Number of subjects: 205
Study 8402734 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18 MIU/m2 IL-2 s.c. once weekly
Number of subjects: 46
Study 8402734 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 MIU/m2 IL-2 s.c. thrice weekly every other day
Number of subjects: 46
Study 8402734 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 MIU/m2 IL-2 s.c. five times weekly every other week
Number of subjects: 46
Study 8402734 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 treatment
Number of subjects: 46
Study 3710959 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g aztreonam iv twice daily for 4 to 15 days
Number of subjects: 39
Study 3710959 — intervention group
Group type: COMPARATOR
Intervention: 1 g cefotaxime iv twice daily for 4 to 15 days
Number of subjects: 39
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 96
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 96
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for NAS
Number of subjects: 96
Study 29413437 — intervention group
Group type: COMPARATOR
Intervention: Control (not treated for NAS)
Number of subjects: 96
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 96
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal parenting stress
Number of subjects: 96
Study 29413437 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal home environment
Number of subjects: 96
Study 26526080 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal Occult Blood Testing (FOBT)
Number of subjects: 997
Study 26526080 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 997
Study 26526080 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice between FOBT and Colonoscopy
Number of subjects: 997
Study 26526080 — intervention group
Group type: COMPARATOR
Intervention: Patient Navigation
Number of subjects: 997
Study 24978441 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/Formoterol Easyhaler (EH)
Number of subjects: 187
Study 24978441 — intervention group
Group type: COMPARATOR
Intervention: Symbicort Turbuhaler (TH)
Number of subjects: 187
Study 22116105 — intervention group
Group type: EXPERIMENTAL
Intervention: MR perfusion imaging
Number of subjects: 59
Study 20537811 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeking Safety intervention
Number of subjects: 0
Study 20537811 — intervention group
Group type: COMPARATOR
Intervention: Health education intervention
Number of subjects: 0
Study 18767580 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture combined with rehabilitation therapy (group C)
Number of subjects: 90
Study 18767580 — intervention group
Group type: COMPARATOR
Intervention: Scalp acupuncture (group A)
Number of subjects: 90
Study 18767580 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation therapy (group B)
Number of subjects: 90
Study 16507374 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D (calcium carbonate 500 mg and vitamin D3 400 IU taken twice daily)
Number of subjects: 192
Study 16507374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 16507374 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium + Vitamin D
Number of subjects: 192
Study 12358234 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (15 mg or 30 mg once daily)
Number of subjects: 692
Study 12358234 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (150 mg b.i.d.)
Number of subjects: 692
Study 10593375 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF levels in follicular fluid
Number of subjects: 16
Study 10593375 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin levels in follicular fluid
Number of subjects: 16
Study 10593375 — intervention group
Group type: EXPERIMENTAL
Intervention: NO levels in follicular fluid
Number of subjects: 16